Home » Topics » BioWorld Science

BioWorld Science
RSS

Innovation announces new agreement to study inhibitory effects of brilacidin on SARS-CoV-2

May 6, 2020

First patients enrolled in pivotal MACOVIA study of MultiStem in COVID-19-induced ARDS

May 6, 2020

Positive topline results from global phase III INNO2VATE program of vadadustat

May 6, 2020

Model created for multiple system atrophy-C and primary progressive multiple sclerosis

May 6, 2020

Vir and Alnylam identify development candidate targeting the SARS-CoV-2 genome

May 6, 2020

How does innate immunity remember? Not via polycomb

May 6, 2020

Where exercise-induced IL-6 comes and goes

May 6, 2020

Promising topline data reported from pivotal trial of Libtayo in advanced BCC

May 5, 2020

Sphingolipid may be new schizophrenia drug target

May 5, 2020

First preclinical results presented for XmAb bispecific antibody AMG-509

May 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...